G & L Research

We're incredibly proud to have played a role in helping bring this drug to market. It's an honor to have contributed to the research that helped make this milestone possible.

NEW OPTION: The FDA has approved the first-ever oral PCSK9 drug for millions of Americans battling high cholesterol.

Lipfendra, made by Merck, reduced LDL cholesterol by 56% to 60% when combined with statins in clinical trials — roughly double the impact of statins alone.

Until now, PCSK9 inhibitors were only available as injections, a factor experts say contributed to their underuse.

👉 Full story here: https://www.foxnews.com/health/game-changing-cholesterol-pill-wins-fda-approval-cutting-ldl-nearly-60

🧻Struggling with chronic constipation? You may qualify for a clinical trial investigating a potential new treatment.

Call G & L Research @ 251-943-2980 to see if you qualify.

May is National Stroke Awareness Month. Knowing the signs of a stroke is important, and you can remember it with F.A.S.T. This can save lives! To learn more, visit alabamapublichealth.gov/cardio/stroke.html.